Skip to main content

Table 1 Characteristics of recruited patients

From: Evaluation of SUVlean consistency in FDG and PSMA PET/MR with Dixon-, James-, and Janma-based lean body mass correction

 

FDG

PSMA

DXA

N

48F, 42M

28M

20F, 20M

Age

58 ± 13 (17~91)

70 ± 7 (56~89)

60 ± 12

Weight (kg)

63 ± 14.4 (37~103)

70.7 ± 8.4 (54~87)

64.7 ± 12.6 (43~94)

BMI

23.11 ± 4.54 (14.5~32.5)

24.47 ± 2.55 (18.7~28.3)

23.47 ± 3.5 (15~31)

Height (cm)

165 ± 7 (150~183)

170 ± 5 (162~180)

165 ± 7 (152~180)

Time (min)

72 ± 14

141 ± 18

/

Dose (mCi/kg)

9.6 ± 1.7%

12.1 ± 3.1%

/

Dose (MBq)

221 ± 50

314 ± 73

/

  1. BMI body mass index, FDG fluorodeoxyglucose, PSMA prostate-specific membrane antigen